Palisade Capital Management LLC Castle Biosciences Inc Transaction History

Palisade Capital Management LLC

$2.94 Billion
Q2 2025

A detailed history of Palisade Capital Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Palisade Capital Management LLC holds 575,116 shares of CSTL stock, worth $13.3 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

575,116

Previous 489,968 17.38%

Holding current value

$13.3 Million

Previous $9.81 Million 19.72%

% of portfolio

0.4%

Previous 0.34%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.8 - $21.98 $1.35 Million - $1.87 Million	85,148 Added 17.38%	575,116 $11.7 Million
Q1 2025 Apr 28, 2025	SELL	$18.76 - $32.72 $252,772 - $440,869	-13,474 Reduced 2.68%	489,968 $9.81 Million
Q4 2024 Feb 14, 2025	BUY	$26.52 - $34.67 $29,835 - $39,003	1,125 Added 0.22%	503,442 $13.4 Million
Q3 2024 Nov 14, 2024	SELL	$17.4 - $31.47 $620,431 - $1.12 Million	-35,657 Reduced 6.63%	502,317 $14.3 Million
Q2 2024 Aug 14, 2024	SELL	$18.84 - $24.94 $173,196 - $229,273	-9,193 Reduced 1.68%	537,974 $11.7 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $145,057 - $203,209	8,032 Added 1.49%	547,167 $12.1 Million
Q4 2023 Feb 14, 2024	SELL	$12.19 - $22.43 $769,505 - $1.42 Million	-63,126 Reduced 10.48%	539,135 $11.6 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $756 - $1,157	57 Added 0.01%	602,261 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $293,668 - $654,836	25,186 Added 4.36%	602,204 $8.26 Million
Q1 2023 May 08, 2023	BUY	$19.47 - $28.49 $504,720 - $738,546	25,923 Added 4.7%	577,018 $13.1 Million
Q4 2022 Feb 14, 2023	SELL	$18.08 - $30.0 $521,589 - $865,470	-28,849 Reduced 4.97%	551,095 $13 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $22,757 - $34,697	1,011 Added 0.17%	579,944 $15.1 Million
Q2 2022 Aug 10, 2022	BUY	$16.0 - $45.99 $2.72 Million - $7.8 Million	169,701 Added 41.47%	578,933 $12.7 Million
Q1 2022 May 09, 2022	BUY	$33.17 - $46.98 $1.88 Million - $2.67 Million	56,791 Added 16.11%	409,232 $18.4 Million
Q4 2021 Feb 10, 2022	BUY	$39.06 - $67.58 $13.8 Million - $23.8 Million	352,441 New	352,441 $15.1 Million

Others Institutions Holding CSTL

# of Institutions

165

Shares Held

27.2M

Call Options Held

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $607M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.

Account

Palisade Capital Management LLC Castle Biosciences Inc Transaction History